SCHEMBL4620096

SCHEMBL4620096

COc1ccc(C(=O)/C=C/c2ccccc2O)cc1OC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 6/20 0.74
ABCB1 P08183 2/20 0.70
TNFRSF1A P19438 2/20 0.68
MAOB P27338 2/20 0.61
MAOA P21397 1/20 0.61
SNCA P37840 1/20 0.60
NR1H4 Q96RI1 1/20 0.60
PDE4A P27815 1/20 0.60
PDE4B Q07343 1/20 0.60
PDE4C Q08493 1/20 0.60
PDE4D Q08499 1/20 0.60
MAPT P10636 2/20 0.59
ATM Q13315 2/20 0.59
NPSR1 Q6W5P4 2/20 0.59
KDM4E B2RXH2 1/20 0.59
NPC1 O15118 1/20 0.59
MAPK1 P28482 1/20 0.59
RAB9A P51151 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
MEN1 O00255 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30428796 1.00 ABCG2 (0.74) ABCG2ABCB1TNFRSF1AMAOBMAOA
SCHEMBL4620101 1.00 ABCG2 (0.74) ABCG2ABCB1TNFRSF1AMAOBMAOA
SCHEMBL5599401 0.92 DPP4 (0.67) ABCG2ABCB1TNFRSF1AMAOBMAOA
SCHEMBL25302141 0.86 ABCG2 (0.74) ABCG2ABCB1TNFRSF1AMAOBNR1H4
SCHEMBL5599587 0.86 PTPN1 (0.57) ABCG2ABCB1TNFRSF1AMAOBMAOA
SCHEMBL14325695 0.85 ABCG2 (0.72) ABCG2ABCB1TNFRSF1AMAOBMAPT
SCHEMBL2971618 0.85 CHRNA7 (0.67) ABCG2ABCB1TNFRSF1ASNCATDP1
SCHEMBL2971621 0.85 CHRNA7 (0.67) ABCG2ABCB1TNFRSF1ASNCATDP1
SCHEMBL3740584 0.84 ABCG2 (0.62) ABCG2ABCB1TNFRSF1ASNCAPDE4A
SCHEMBL29684615 0.83 ABCG2 (0.69) ABCG2ABCB1TNFRSF1AMAPTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116162079-A Synthesis method of aminocoumarin compound 浙江工业大学 2023-05-26 CN disclosed
EP-1888174-A1 USE OF CHALCONES FOR THE TREATMENT OF VIRAL DISORDERS Johnson and Johnson Consumer Companies, Inc. (US) 2008-02-20 EP disclosed
WO-2006127539-A1 USE OF CHALCONES FOR THE TREATMENT OF VIRAL DISORDERS JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2006-11-30 WO disclosed
EP-0428398-A2 Radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1991-05-22 EP disclosed